Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post-transplant cyclophosphamide.
Maxime JullienCorentin OrvainAna BerceanuMarie-Anne CouturierThierry GuillaumePierre PeterlinAlice GarnierAmandine Le BourgeoisMarion KlemencieAline SchmidtMathilde HunaultEtienne DaguindauXavier RousselPascal DelepineGaelle GuillermAurelien GiltatSylvie FrançoisSylvain ThepotSteven Le GouillMarie-C BénéPatrice ChevallierPublished in: Cancer medicine (2021)
The comorbidity scores do not predict survivals nor NRM in haploidentical Allo-HSCT with PTCY, suggesting that pre-transplant comorbidities should not be a contra-indication to this procedure.